• December 2004: Development of the business idea for onepharm together with AVIR Green Hills Biotechnology.

• March-May 2005: Creation of the business plan, establishment of scientific board.

• June 2005: Best of Biotech finalist and seed financing granted by the Austrian Wirtschafts Service (AWS). Best of Biotech is an established business plan competition by the Austrian government.

• July 2005: Foundation of onepharm by management and Green Hills Biotechnology.

• July-August 2005: Establishment of shareholder agreement and main licensing contracts.

• September 2005: Operational start of onepharm.

• November 2005: Otto Doblhoff joins onepharm as COO.

• January 2006: Core team established.

• March 2006: Financial commitments of EUR 3,5 Million secured

• June 2007: Additional EUR 2 Million secured

• July 2007: Oliver Szolar nominated CSO, onepharm expands team

• August 2007: onepharm moves operations to VUW research campus

• January 2008: Periodontitis data confirmed in the rat model

• April 2008: In total financing of 8 Mio Euro secured

• March 2009: Acquisition of IBD patent from WuHan WuHana Biochemicals

• August 2009: onepharm focusses on periodontal disease and spins out anti-viral research and together with EMBL founds Savira Pharmaceuticals.

For more information: onepharm news